Cellebrite DI Ltd.
NASDAQCellebrite DI is experiencing one of its sharpest weekly declines in recent memory, down 30% to $11.14, even as options positioning swings aggressively to the buy side — a split signal that makes this week's setup genuinely unusual. The clearest divergence sits in the options market. Traders have turned sharply bullish, with the put/call ratio collapsing to 0.19 on August 14 — more…
CLBT short interest declines 20.8% in one week to 1.63% of float, pulling back from elevated levels seen in early May.
Snapshot as of 16 Aug 2026
Cellebrite DI is experiencing one of its sharpest weekly declines in recent memory, down 30% to $11.14, even as options positioning swings aggressively to the buy side — a split signal that makes this week's setup…
Options traders at Cellebrite DI are more defensive than at any point in recent months — and a new buy rating filed this week has done little to reverse the week's losses. The sharpest signal this week is in the…
CLBT has recovered 5% this week to $13.35, but the stock is still down 26% year-to-date — and with Q1 earnings now just 12 days away on May 14, the options market is flashing a more cautious read than the week's price…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for CLBT — free to start on ORTEX.
Sign up for free →Open CLBT on ORTEX